Heart Test Laboratories (HSCS) Income Statement (2021 - 2026)
Income Statement report data from Jul 31, 2021 to Jan 31, 2026 for Heart Test Laboratories (HSCS).
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Reported currency: USD
| Jan 31, 2026 | Oct 31, 2025 | Jul 31, 2025 | Apr 30, 2025 | Jan 31, 2025 | Oct 31, 2024 | Jul 31, 2024 | Apr 30, 2024 | Jan 31, 2024 | Oct 31, 2023 | Jul 31, 2023 | Apr 30, 2023 | Jan 31, 2023 | Oct 31, 2022 | Jul 31, 2022 | Apr 30, 2022 | Jan 31, 2022 | Oct 31, 2021 | Jul 31, 2021 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue and COGS | |||||||||||||||||||
Total Revenue | - | - | - | - | - | - | - | - | 10K | - | - | - | - | - | - | - | - | - | 10K |
Cost Of Revenue | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10K |
Costof Goods And Services Sold | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | 10K |
Gross Profit | - | - | - | - | - | - | - | - | 10K | - | - | - | - | - | - | - | - | - | - |
Operating Expenses | |||||||||||||||||||
Research And Development | 640K (-12.33%) | 730K (-27.00%) | 1.00M (+7.53%) | 930K (-9.71%) | 1.03M (-14.17%) | 1.20M (-1.64%) | 1.22M (+16.19%) | 1.05M (+105.88%) | 510K (-32.89%) | 760K (+33.33%) | 570K (+7.55%) | 530K (-17.19%) | 640K (-24.71%) | 850K (+97.67%) | 430K (-68.38%) | 1.36M (+94.29%) | 700K (+27.27%) | 550K (+37.50%) | 400K |
Selling General And Administrative | 1.29M (-4.44%) | 1.35M (+53.41%) | 880K (-11.11%) | 990K (-26.12%) | 1.34M (+69.62%) | 790K (-7.06%) | 850K (+2.41%) | 830K (-19.42%) | 1.03M (+25.61%) | 820K (+6.49%) | 770K (-27.36%) | 1.06M (+58.21%) | 670K (-27.96%) | 930K (-7.00%) | 1.00M (+58.73%) | 630K (+57.50%) | 400K (-2.44%) | 410K (+46.43%) | 280K |
Operating Expenses | 1.93M (-6.76%) | 2.07M (+10.11%) | 1.88M (-2.08%) | 1.92M (-18.99%) | 2.37M (+19.10%) | 1.99M (-4.33%) | 2.08M (+10.64%) | 1.88M (+22.08%) | 1.54M (-1.91%) | 1.57M (+18.05%) | 1.33M (-16.88%) | 1.60M (+22.14%) | 1.31M (-25.99%) | 1.77M (+23.78%) | 1.43M (-27.78%) | 1.98M (+80.00%) | 1.10M (+14.58%) | 960K (+41.18%) | 680K |
Depreciation And Amortization | - | - | 10K (-66.67%) | 30K | - | - | 10K (-50.00%) | 20K | - | - | 10K (-50.00%) | 20K | - | - | 10K (-50.00%) | 20K | - | - | 10K |
Operating Income | |||||||||||||||||||
Operating Income | -1.93M (-6.76%) | -2.07M (+10.70%) | -1.87M (-2.60%) | -1.92M (-18.99%) | -2.37M (+19.10%) | -1.99M (-4.33%) | -2.08M (+10.64%) | -1.88M (+22.88%) | -1.53M (-2.55%) | -1.57M (+18.05%) | -1.33M (-16.88%) | -1.60M (+22.14%) | -1.31M (-25.99%) | -1.77M (+23.78%) | -1.43M (-27.78%) | -1.98M (+80.00%) | -1.10M (+14.58%) | -960.00K (+43.28%) | -670.00K |
Ebit | -1.93M (-6.76%) | -2.07M (+10.70%) | -1.87M (-2.60%) | -1.92M (-18.99%) | -2.37M (+19.10%) | -1.99M (-4.33%) | -2.08M (+10.64%) | -1.88M (+22.88%) | -1.53M (-2.55%) | -1.57M (+18.05%) | -1.33M (-16.88%) | -1.60M (+22.14%) | -1.31M (-25.99%) | -1.77M (+23.78%) | -1.43M (-27.78%) | -1.98M (+80.00%) | -1.10M (+14.58%) | -960.00K (+43.28%) | -670.00K |
EBITDA | -1.92M (-7.25%) | -2.07M (+10.70%) | -1.87M (-3.11%) | -1.93M (-18.22%) | -2.36M (+19.80%) | -1.97M (-4.37%) | -2.06M (+10.75%) | -1.86M (+21.57%) | -1.53M (-2.55%) | -1.57M (+18.94%) | -1.32M (-16.46%) | -1.58M (+20.61%) | -1.31M (-25.99%) | -1.77M (+24.65%) | -1.42M (-27.55%) | -1.96M (+78.18%) | -1.10M (+14.58%) | -960.00K (+43.28%) | -670.00K |
Other Income / Expenses | |||||||||||||||||||
Interest Expense | 60K (-78.57%) | 280K (+55.56%) | 180K (0.00%) | 180K (0.00%) | 180K (+50.00%) | 120K (+500.00%) | 20K (0.00%) | 20K (-83.33%) | 120K (-33.33%) | 180K (+350.00%) | 40K (+33.33%) | 30K (0.00%) | 30K (0.00%) | 30K (-78.57%) | 140K (+75.00%) | 80K (-42.86%) | 140K (+75.00%) | 80K (0.00%) | 80K |
Net Interest Income | - | - | - | - | - | - | - | -20.00K (-83.33%) | -120.00K (-33.33%) | -180.00K (+350.00%) | -40.00K (+33.33%) | -30.00K (0.00%) | -30.00K (0.00%) | -30.00K (-78.57%) | -140.00K (+75.00%) | -80.00K (-42.86%) | -140.00K (+75.00%) | -80.00K (0.00%) | -80.00K |
Other Non Operating Income | 10K | -280.00K (+55.56%) | -180.00K (-56.10%) | -410.00K | 10K | -100.00K | 20K | -300.00K (+150.00%) | -120.00K (-33.33%) | -180.00K (+350.00%) | -40.00K (-83.33%) | -240.00K (+700.00%) | -30.00K (0.00%) | -30.00K (-78.57%) | -140.00K (+16.67%) | -120.00K (-14.29%) | -140.00K (+75.00%) | -80.00K | 170K |
Net Income | |||||||||||||||||||
Net Income From Continuing Operations | -1.99M (-15.32%) | -2.35M (+14.63%) | -2.05M (-1.91%) | -2.09M (-17.72%) | -2.54M (+22.12%) | -2.08M (+1.46%) | -2.05M (+10.81%) | -1.85M (+12.80%) | -1.64M (-6.29%) | -1.75M (+27.74%) | -1.37M (-15.95%) | -1.63M (+21.64%) | -1.34M (-25.97%) | -1.81M (+15.29%) | -1.57M (-23.41%) | -2.05M (+65.32%) | -1.24M (+20.39%) | -1.03M (+106.00%) | -500.00K |
Net Income | -1.99M (-15.32%) | -2.35M (+14.63%) | -2.05M (-1.91%) | -2.09M (-17.72%) | -2.54M (+22.12%) | -2.08M (+1.46%) | -2.05M (+10.81%) | -1.85M (+12.80%) | -1.64M (-6.29%) | -1.75M (+27.74%) | -1.37M (-15.95%) | -1.63M (+21.64%) | -1.34M (-25.97%) | -1.81M (+15.29%) | -1.57M (-23.41%) | -2.05M (+65.32%) | -1.24M (+20.39%) | -1.03M (+106.00%) | -500.00K |